Japan to undertake iPS cell trials in coming years

06/25/2009 | Breitbart.com

Japan reportedly is planning within five years to conduct clinical trials on induced pluripotent stem cells aimed at producing retinal pigment epithelial cells to cure age-related macular degeneration and hematopoietic stem cells to treat blood conditions, among other treatments. The plan also calls for the creation of an iPS cell bank within two years.

View Full Article in:

Breitbart.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Paralegal
Mylan Inc.
Washington, DC
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA